Literature DB >> 26266742

Structural Evidence of Amyloid Fibril Formation in the Putative Aggregation Domain of TDP-43.

Miguel Mompeán1, Rubén Hervás2,3, Yunyao Xu4, Timothy H Tran5, Corrado Guarnaccia6, Emanuele Buratti6, Francisco Baralle6, Liang Tong5, Mariano Carrión-Vázquez2,3, Ann E McDermott4, Douglas V Laurents1.   

Abstract

TDP-43 can form pathological proteinaceous aggregates linked to ALS and FTLD. Within the putative aggregation domain, engineered repeats of residues 341-366 can recruit endogenous TDP-43 into aggregates inside cells; however, the nature of these aggregates is a debatable issue. Recently, we showed that a coil to β-hairpin transition in a short peptide corresponding to TDP-43 residues 341-357 enables oligomerization. Here we provide definitive structural evidence for amyloid formation upon extensive characterization of TDP-43(341-357) via chromophore and antibody binding, electron microscopy (EM), solid-state NMR, and X-ray diffraction. On the basis of these findings, structural models for TDP-43(341-357) oligomers were constructed, refined, verified, and analyzed using docking, molecular dynamics, and semiempirical quantum mechanics methods. Interestingly, TDP-43(341-357) β-hairpins assemble into a novel parallel β-turn configuration showing cross-β spine, cooperative H-bonding, and tight side-chain packing. These results expand the amyloid foldome and could guide the development of future therapeutics to prevent this structural conversion.

Entities:  

Keywords:  X-ray diffraction; amyloid; amyotrophic lateral schlerosis; cross-beta spine; molecular dynamics

Mesh:

Substances:

Year:  2015        PMID: 26266742      PMCID: PMC5568655          DOI: 10.1021/acs.jpclett.5b00918

Source DB:  PubMed          Journal:  J Phys Chem Lett        ISSN: 1948-7185            Impact factor:   6.475


  42 in total

1.  Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening.

Authors:  Y Nagai; T Tucker; H Ren; D J Kenan; B S Henderson; J D Keene; W J Strittmatter; J R Burke
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

Review 2.  TDP-43: gumming up neurons through protein-protein and protein-RNA interactions.

Authors:  Emanuele Buratti; Francisco E Baralle
Journal:  Trends Biochem Sci       Date:  2012-04-24       Impact factor: 13.807

3.  "Structural characterization of the minimal segment of TDP-43 competent for aggregation".

Authors:  Miguel Mompeán; Emanuele Buratti; Corrado Guarnaccia; Rui M M Brito; Avijit Chakrabartty; Francisco E Baralle; Douglas V Laurents
Journal:  Arch Biochem Biophys       Date:  2014-01-15       Impact factor: 4.013

4.  Combining Classical MD and QM calculations to elucidate complex system nucleation: a twisted, three-stranded, parallel β-sheet seeds amyloid fibril conception.

Authors:  Miguel Mompeán; Carlos González; Enrique Lomba; Douglas V Laurents
Journal:  J Phys Chem B       Date:  2014-06-24       Impact factor: 2.991

5.  Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent.

Authors:  Karunakar Kar; Murali Jayaraman; Bankanidhi Sahoo; Ravindra Kodali; Ronald Wetzel
Journal:  Nat Struct Mol Biol       Date:  2011-02-13       Impact factor: 15.369

6.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

7.  Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients.

Authors:  Yu-Sheng Fang; Kuen-Jer Tsai; Yu-Jen Chang; Patricia Kao; Rima Woods; Pan-Hsien Kuo; Cheng-Chun Wu; Jhih-Ying Liao; Shih-Chieh Chou; Vinson Lin; Lee-Way Jin; Hanna S Yuan; Irene H Cheng; Pang-Hsien Tu; Yun-Ru Chen
Journal:  Nat Commun       Date:  2014-09-12       Impact factor: 14.919

8.  TDP-43 skeins show properties of amyloid in a subset of ALS cases.

Authors:  John L Robinson; Felix Geser; Anna Stieber; Mfon Umoh; Linda K Kwong; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2012-11-03       Impact factor: 17.088

9.  Improved side-chain torsion potentials for the Amber ff99SB protein force field.

Authors:  Kresten Lindorff-Larsen; Stefano Piana; Kim Palmo; Paul Maragakis; John L Klepeis; Ron O Dror; David E Shaw
Journal:  Proteins       Date:  2010-06

10.  Common features at the start of the neurodegeneration cascade.

Authors:  Rubén Hervás; Javier Oroz; Albert Galera-Prat; Oscar Goñi; Alejandro Valbuena; Andrés M Vera; Angel Gómez-Sicilia; Fernando Losada-Urzáiz; Vladimir N Uversky; Margarita Menéndez; Douglas V Laurents; Marta Bruix; Mariano Carrión-Vázquez
Journal:  PLoS Biol       Date:  2012-05-29       Impact factor: 8.029

View more
  23 in total

1.  Dysregulation of TDP-43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant.

Authors:  Kathy Newell; Francesca Paron; Miguel Mompean; Jill Murrell; Elisa Salis; Cristiana Stuani; Gary Pattee; Maurizio Romano; Douglas Laurents; Bernardino Ghetti; Emanuele Buratti
Journal:  Brain Pathol       Date:  2018-12-27       Impact factor: 6.508

2.  TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues.

Authors:  Hao-Ru Li; Wan-Chin Chiang; Po-Chun Chou; Won-Jing Wang; Jie-Rong Huang
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

Review 3.  Insights into protein misfolding and aggregation enabled by solid-state NMR spectroscopy.

Authors:  Patrick C A van der Wel
Journal:  Solid State Nucl Magn Reson       Date:  2017-10-04       Impact factor: 2.293

4.  Morphology and Distribution of TDP-43 Pre-inclusions in Primary Progressive Aphasia.

Authors:  Garam Kim; Kabriya Bolbolan; Ryan Shahidehpour; Pouya Jamshidi; Tamar Gefen; Ivan A Ayala; Sandra Weintraub; Eileen H Bigio; Marek-Marsel Mesulam; Changiz Geula
Journal:  J Neuropathol Exp Neurol       Date:  2019-03-01       Impact factor: 3.685

5.  Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.

Authors:  Rachel L French; Zachary R Grese; Himani Aligireddy; Dhruva D Dhavale; Ashley N Reeb; Niraja Kedia; Paul T Kotzbauer; Jan Bieschke; Yuna M Ayala
Journal:  J Biol Chem       Date:  2019-03-01       Impact factor: 5.157

6.  Modulation of assembly of TDP-43 low-complexity domain by heparin: From droplets to amyloid fibrils.

Authors:  Dushyant Kumar Garg; Rajiv Bhat
Journal:  Biophys J       Date:  2022-05-28       Impact factor: 3.699

7.  Head-to-Head Comparison of Tau-PET Radioligands for Imaging TDP-43 in Post-Mortem ALS Brain.

Authors:  Ashley C Knight; Christopher D Morrone; Cassis Varlow; Wai Haung Yu; Paul McQuade; Neil Vasdev
Journal:  Mol Imaging Biol       Date:  2022-10-18       Impact factor: 3.484

8.  Point mutations in the N-terminal domain of transactive response DNA-binding protein 43 kDa (TDP-43) compromise its stability, dimerization, and functions.

Authors:  Miguel Mompeán; Valentina Romano; David Pantoja-Uceda; Cristiana Stuani; Francisco E Baralle; Emanuele Buratti; Douglas V Laurents
Journal:  J Biol Chem       Date:  2017-05-31       Impact factor: 5.157

9.  Trends in Understanding the Pathological Roles of TDP-43 and FUS Proteins.

Authors:  Emanuele Buratti
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis.

Authors:  E Srinivasan; R Rajasekaran
Journal:  J Mol Neurosci       Date:  2020-05-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.